nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—CA2—osteoporosis	0.428	1	CbGaD
Hydroflumethiazide—CA14—Zoledronate—osteoporosis	0.187	0.438	CbGbCtD
Hydroflumethiazide—CA12—Zoledronate—osteoporosis	0.133	0.311	CbGbCtD
Hydroflumethiazide—CA2—Zoledronate—osteoporosis	0.107	0.251	CbGbCtD
Hydroflumethiazide—CA14—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00553	0.0931	CbGpPWpGaD
Hydroflumethiazide—CA5B—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00503	0.0847	CbGpPWpGaD
Hydroflumethiazide—CA7—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00503	0.0847	CbGpPWpGaD
Hydroflumethiazide—Xanthopsia—Pamidronate—osteoporosis	0.00496	0.0609	CcSEcCtD
Hydroflumethiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00467	0.0787	CbGpPWpGaD
Hydroflumethiazide—CA12—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00466	0.0784	CbGpPWpGaD
Hydroflumethiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.0043	0.0724	CbGpPWpGaD
Hydroflumethiazide—CA4—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00371	0.0625	CbGpPWpGaD
Hydroflumethiazide—CA1—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00341	0.0575	CbGpPWpGaD
Hydroflumethiazide—CA9—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.003	0.0505	CbGpPWpGaD
Hydroflumethiazide—Epigastric discomfort—Calcitriol—osteoporosis	0.00215	0.0264	CcSEcCtD
Hydroflumethiazide—Gastric irritation—Conjugated Estrogens—osteoporosis	0.00206	0.0252	CcSEcCtD
Hydroflumethiazide—Epigastric discomfort—Conjugated Estrogens—osteoporosis	0.00152	0.0186	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Estropipate—osteoporosis	0.00137	0.0169	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.00104	0.0175	CbGpPWpGaD
Hydroflumethiazide—Photosensitivity—Alendronate—osteoporosis	0.000983	0.0121	CcSEcCtD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—ID4—osteoporosis	0.000958	0.0161	CbGpPWpGaD
Hydroflumethiazide—Bendroflumethiazide—CA2—osteoporosis	0.000927	0.205	CrCbGaD
Hydroflumethiazide—Purpura—Estropipate—osteoporosis	0.000909	0.0112	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.000908	0.0111	CcSEcCtD
Hydroflumethiazide—Methyclothiazide—CA2—osteoporosis	0.000813	0.18	CrCbGaD
Hydroflumethiazide—Cramp muscle—Estropipate—osteoporosis	0.000789	0.00968	CcSEcCtD
Hydroflumethiazide—Cyclothiazide—CA2—osteoporosis	0.000788	0.174	CrCbGaD
Hydroflumethiazide—Chlorothiazide—CA2—osteoporosis	0.000783	0.173	CrCbGaD
Hydroflumethiazide—Cramp muscle—Alendronate—osteoporosis	0.000777	0.00954	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Ibandronate—osteoporosis	0.000757	0.00929	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Estropipate—osteoporosis	0.000742	0.00911	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etidronic acid—osteoporosis	0.000728	0.00894	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Estradiol—osteoporosis	0.000726	0.00892	CcSEcCtD
Hydroflumethiazide—Anorexia—Calcium Acetate—osteoporosis	0.000723	0.00887	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Calcitriol—osteoporosis	0.000697	0.00855	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Estropipate—osteoporosis	0.000683	0.00838	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Alendronate—osteoporosis	0.000681	0.00836	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Calcium Acetate—osteoporosis	0.000659	0.00809	CcSEcCtD
Hydroflumethiazide—Constipation—Calcium Acetate—osteoporosis	0.000648	0.00796	CcSEcCtD
Hydroflumethiazide—Hydrochlorothiazide—CA2—osteoporosis	0.000643	0.142	CrCbGaD
Hydroflumethiazide—Anorexia—Ergocalciferol—osteoporosis	0.000638	0.00784	CcSEcCtD
Hydroflumethiazide—Purpura—Conjugated Estrogens—osteoporosis	0.000601	0.00737	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Pamidronate—osteoporosis	0.000593	0.00728	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etidronic acid—osteoporosis	0.000586	0.0072	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Ergocalciferol—osteoporosis	0.000582	0.00715	CcSEcCtD
Hydroflumethiazide—Trichlormethiazide—CA2—osteoporosis	0.000573	0.127	CrCbGaD
Hydroflumethiazide—Constipation—Ergocalciferol—osteoporosis	0.000573	0.00703	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Calcium Acetate—osteoporosis	0.000559	0.00686	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etidronic acid—osteoporosis	0.000546	0.0067	CcSEcCtD
Hydroflumethiazide—Asthenia—Calcium Acetate—osteoporosis	0.000544	0.00668	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Zoledronate—osteoporosis	0.000541	0.00665	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Conjugated Estrogens—osteoporosis	0.000521	0.0064	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Calcium Acetate—osteoporosis	0.000519	0.00637	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Estradiol—osteoporosis	0.000518	0.00636	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Estropipate—osteoporosis	0.000507	0.00623	CcSEcCtD
Hydroflumethiazide—Dizziness—Calcium Acetate—osteoporosis	0.000501	0.00615	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Alendronate—osteoporosis	0.0005	0.00613	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Raloxifene—osteoporosis	0.000491	0.00603	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000491	0.00602	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Ibandronate—osteoporosis	0.000486	0.00597	CcSEcCtD
Hydroflumethiazide—Vomiting—Calcium Acetate—osteoporosis	0.000482	0.00592	CcSEcCtD
Hydroflumethiazide—Purpura—Estradiol—osteoporosis	0.000481	0.0059	CcSEcCtD
Hydroflumethiazide—Asthenia—Ergocalciferol—osteoporosis	0.00048	0.0059	CcSEcCtD
Hydroflumethiazide—Vertigo—Estropipate—osteoporosis	0.000474	0.00582	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Pamidronate—osteoporosis	0.000473	0.00581	CcSEcCtD
Hydroflumethiazide—CA1—C-MYB transcription factor network—COL1A2—osteoporosis	0.000468	0.00788	CbGpPWpGaD
Hydroflumethiazide—Vertigo—Alendronate—osteoporosis	0.000467	0.00573	CcSEcCtD
Hydroflumethiazide—Vertigo—Raloxifene—osteoporosis	0.000459	0.00564	CcSEcCtD
Hydroflumethiazide—Agitation—Calcitriol—osteoporosis	0.000455	0.00559	CcSEcCtD
Hydroflumethiazide—Vertigo—Ibandronate—osteoporosis	0.000455	0.00558	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000451	0.00554	CcSEcCtD
Hydroflumethiazide—Nausea—Calcium Acetate—osteoporosis	0.00045	0.00553	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Zoledronate—osteoporosis	0.000432	0.00531	CcSEcCtD
Hydroflumethiazide—Constipation—Etidronic acid—osteoporosis	0.000426	0.00522	CcSEcCtD
Hydroflumethiazide—CA1—C-MYB transcription factor network—WNT1—osteoporosis	0.000425	0.00716	CbGpPWpGaD
Hydroflumethiazide—Cramp muscle—Estradiol—osteoporosis	0.000417	0.00512	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000411	0.00505	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Raloxifene—osteoporosis	0.000408	0.00501	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Risedronate—osteoporosis	0.000401	0.00492	CcSEcCtD
Hydroflumethiazide—Nausea—Ergocalciferol—osteoporosis	0.000398	0.00488	CcSEcCtD
Hydroflumethiazide—Urticaria—Etidronic acid—osteoporosis	0.000395	0.00485	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.000393	0.00662	CbGpPWpGaD
Hydroflumethiazide—Pancreatitis—Estradiol—osteoporosis	0.000393	0.00482	CcSEcCtD
Hydroflumethiazide—Anorexia—Calcitriol—osteoporosis	0.000385	0.00473	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Pamidronate—osteoporosis	0.000381	0.00468	CcSEcCtD
Hydroflumethiazide—Vertigo—Risedronate—osteoporosis	0.000375	0.0046	CcSEcCtD
Hydroflumethiazide—Constipation—Estropipate—osteoporosis	0.000368	0.00452	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etidronic acid—osteoporosis	0.000367	0.0045	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Estradiol—osteoporosis	0.000366	0.00449	CcSEcCtD
Hydroflumethiazide—Agitation—Pamidronate—osteoporosis	0.000364	0.00447	CcSEcCtD
Hydroflumethiazide—Constipation—Alendronate—osteoporosis	0.000363	0.00445	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Estradiol—osteoporosis	0.000361	0.00443	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Ibandronate—osteoporosis	0.000359	0.00441	CcSEcCtD
Hydroflumethiazide—Leukopenia—Pamidronate—osteoporosis	0.000355	0.00436	CcSEcCtD
Hydroflumethiazide—Constipation—Ibandronate—osteoporosis	0.000353	0.00433	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Calcitriol—osteoporosis	0.000351	0.00431	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Zoledronate—osteoporosis	0.000348	0.00427	CcSEcCtD
Hydroflumethiazide—Jaundice—Estradiol—osteoporosis	0.000348	0.00427	CcSEcCtD
Hydroflumethiazide—Constipation—Calcitriol—osteoporosis	0.000346	0.00424	CcSEcCtD
Hydroflumethiazide—Urticaria—Estropipate—osteoporosis	0.000342	0.0042	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etidronic acid—osteoporosis	0.000341	0.00418	CcSEcCtD
Hydroflumethiazide—Urticaria—Alendronate—osteoporosis	0.000337	0.00414	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000335	0.00411	CcSEcCtD
Hydroflumethiazide—Agitation—Zoledronate—osteoporosis	0.000333	0.00408	CcSEcCtD
Hydroflumethiazide—Urticaria—Ibandronate—osteoporosis	0.000328	0.00403	CcSEcCtD
Hydroflumethiazide—CA9—Cellular responses to stress—PRDX3—osteoporosis	0.000325	0.00548	CbGpPWpGaD
Hydroflumethiazide—Vertigo—Zoledronate—osteoporosis	0.000325	0.00399	CcSEcCtD
Hydroflumethiazide—Leukopenia—Zoledronate—osteoporosis	0.000324	0.00398	CcSEcCtD
Hydroflumethiazide—Urticaria—Calcitriol—osteoporosis	0.000321	0.00394	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—WDR1—osteoporosis	0.000317	0.00535	CbGpPWpGaD
Hydroflumethiazide—Hypersensitivity—Estropipate—osteoporosis	0.000317	0.00389	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Pamidronate—osteoporosis	0.000317	0.00389	CcSEcCtD
Hydroflumethiazide—Vomiting—Etidronic acid—osteoporosis	0.000316	0.00388	CcSEcCtD
Hydroflumethiazide—Rash—Etidronic acid—osteoporosis	0.000314	0.00385	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etidronic acid—osteoporosis	0.000314	0.00385	CcSEcCtD
Hydroflumethiazide—Vertigo—Conjugated Estrogens—osteoporosis	0.000313	0.00384	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Alendronate—osteoporosis	0.000312	0.00384	CcSEcCtD
Hydroflumethiazide—Headache—Etidronic acid—osteoporosis	0.000312	0.00383	CcSEcCtD
Hydroflumethiazide—Asthenia—Estropipate—osteoporosis	0.000309	0.00379	CcSEcCtD
Hydroflumethiazide—Anorexia—Pamidronate—osteoporosis	0.000308	0.00378	CcSEcCtD
Hydroflumethiazide—Asthenia—Alendronate—osteoporosis	0.000304	0.00374	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ibandronate—osteoporosis	0.000304	0.00373	CcSEcCtD
Hydroflumethiazide—Constipation—Ethinyl Estradiol—osteoporosis	0.000298	0.00366	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Calcitriol—osteoporosis	0.000298	0.00366	CcSEcCtD
Hydroflumethiazide—Asthenia—Ibandronate—osteoporosis	0.000296	0.00364	CcSEcCtD
Hydroflumethiazide—Nausea—Etidronic acid—osteoporosis	0.000296	0.00363	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Estropipate—osteoporosis	0.000295	0.00362	CcSEcCtD
Hydroflumethiazide—Constipation—Risedronate—osteoporosis	0.000291	0.00357	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Alendronate—osteoporosis	0.00029	0.00356	CcSEcCtD
Hydroflumethiazide—Asthenia—Calcitriol—osteoporosis	0.00029	0.00356	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Zoledronate—osteoporosis	0.000289	0.00355	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Raloxifene—osteoporosis	0.000285	0.0035	CcSEcCtD
Hydroflumethiazide—Dizziness—Estropipate—osteoporosis	0.000285	0.0035	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ibandronate—osteoporosis	0.000283	0.00347	CcSEcCtD
Hydroflumethiazide—Anorexia—Zoledronate—osteoporosis	0.000282	0.00346	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Pamidronate—osteoporosis	0.000281	0.00345	CcSEcCtD
Hydroflumethiazide—Dizziness—Alendronate—osteoporosis	0.00028	0.00344	CcSEcCtD
Hydroflumethiazide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000277	0.0034	CcSEcCtD
Hydroflumethiazide—Constipation—Pamidronate—osteoporosis	0.000277	0.0034	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Calcitriol—osteoporosis	0.000277	0.00339	CcSEcCtD
Hydroflumethiazide—Dizziness—Raloxifene—osteoporosis	0.000276	0.00339	CcSEcCtD
Hydroflumethiazide—Vomiting—Estropipate—osteoporosis	0.000274	0.00336	CcSEcCtD
Hydroflumethiazide—Dizziness—Ibandronate—osteoporosis	0.000273	0.00335	CcSEcCtD
Hydroflumethiazide—Rash—Estropipate—osteoporosis	0.000271	0.00333	CcSEcCtD
Hydroflumethiazide—Dermatitis—Estropipate—osteoporosis	0.000271	0.00333	CcSEcCtD
Hydroflumethiazide—Anorexia—Conjugated Estrogens—osteoporosis	0.000271	0.00333	CcSEcCtD
Hydroflumethiazide—Urticaria—Risedronate—osteoporosis	0.00027	0.00332	CcSEcCtD
Hydroflumethiazide—Headache—Estropipate—osteoporosis	0.00027	0.00331	CcSEcCtD
Hydroflumethiazide—Vomiting—Alendronate—osteoporosis	0.00027	0.00331	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Estradiol—osteoporosis	0.000268	0.00329	CcSEcCtD
Hydroflumethiazide—Rash—Alendronate—osteoporosis	0.000267	0.00328	CcSEcCtD
Hydroflumethiazide—Dermatitis—Alendronate—osteoporosis	0.000267	0.00328	CcSEcCtD
Hydroflumethiazide—Headache—Alendronate—osteoporosis	0.000266	0.00326	CcSEcCtD
Hydroflumethiazide—Vomiting—Raloxifene—osteoporosis	0.000265	0.00326	CcSEcCtD
Hydroflumethiazide—Rash—Raloxifene—osteoporosis	0.000263	0.00323	CcSEcCtD
Hydroflumethiazide—Dermatitis—Raloxifene—osteoporosis	0.000263	0.00323	CcSEcCtD
Hydroflumethiazide—Vomiting—Ibandronate—osteoporosis	0.000263	0.00322	CcSEcCtD
Hydroflumethiazide—Headache—Raloxifene—osteoporosis	0.000261	0.00321	CcSEcCtD
Hydroflumethiazide—Rash—Ibandronate—osteoporosis	0.00026	0.0032	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ibandronate—osteoporosis	0.00026	0.00319	CcSEcCtD
Hydroflumethiazide—Headache—Ibandronate—osteoporosis	0.000259	0.00318	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000257	0.00316	CcSEcCtD
Hydroflumethiazide—Vomiting—Calcitriol—osteoporosis	0.000257	0.00315	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Zoledronate—osteoporosis	0.000257	0.00315	CcSEcCtD
Hydroflumethiazide—Agitation—Estradiol—osteoporosis	0.000256	0.00315	CcSEcCtD
Hydroflumethiazide—Nausea—Estropipate—osteoporosis	0.000256	0.00314	CcSEcCtD
Hydroflumethiazide—Rash—Calcitriol—osteoporosis	0.000255	0.00313	CcSEcCtD
Hydroflumethiazide—Dermatitis—Calcitriol—osteoporosis	0.000255	0.00313	CcSEcCtD
Hydroflumethiazide—Headache—Calcitriol—osteoporosis	0.000253	0.00311	CcSEcCtD
Hydroflumethiazide—Constipation—Zoledronate—osteoporosis	0.000253	0.0031	CcSEcCtD
Hydroflumethiazide—Nausea—Alendronate—osteoporosis	0.000252	0.00309	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—CAP1—osteoporosis	0.000251	0.00423	CbGpPWpGaD
Hydroflumethiazide—Hypersensitivity—Risedronate—osteoporosis	0.000251	0.00308	CcSEcCtD
Hydroflumethiazide—Vertigo—Estradiol—osteoporosis	0.000251	0.00308	CcSEcCtD
Hydroflumethiazide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00025	0.00307	CcSEcCtD
Hydroflumethiazide—Nausea—Raloxifene—osteoporosis	0.000248	0.00304	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000247	0.00304	CcSEcCtD
Hydroflumethiazide—Nausea—Ibandronate—osteoporosis	0.000245	0.00301	CcSEcCtD
Hydroflumethiazide—Asthenia—Risedronate—osteoporosis	0.000244	0.003	CcSEcCtD
Hydroflumethiazide—Constipation—Conjugated Estrogens—osteoporosis	0.000243	0.00299	CcSEcCtD
Hydroflumethiazide—Nausea—Calcitriol—osteoporosis	0.00024	0.00295	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000239	0.00293	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Pamidronate—osteoporosis	0.000238	0.00293	CcSEcCtD
Hydroflumethiazide—Urticaria—Zoledronate—osteoporosis	0.000235	0.00288	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Risedronate—osteoporosis	0.000233	0.00286	CcSEcCtD
Hydroflumethiazide—Asthenia—Pamidronate—osteoporosis	0.000232	0.00285	CcSEcCtD
Hydroflumethiazide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000231	0.00283	CcSEcCtD
Hydroflumethiazide—Urticaria—Conjugated Estrogens—osteoporosis	0.000226	0.00277	CcSEcCtD
Hydroflumethiazide—Dizziness—Risedronate—osteoporosis	0.000225	0.00276	CcSEcCtD
Hydroflumethiazide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000222	0.00272	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Pamidronate—osteoporosis	0.000221	0.00272	CcSEcCtD
Hydroflumethiazide—Rash—Ethinyl Estradiol—osteoporosis	0.00022	0.0027	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00022	0.0027	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00022	0.0037	CbGpPWpGaD
Hydroflumethiazide—Headache—Ethinyl Estradiol—osteoporosis	0.000219	0.00268	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Zoledronate—osteoporosis	0.000218	0.00267	CcSEcCtD
Hydroflumethiazide—Vomiting—Risedronate—osteoporosis	0.000216	0.00266	CcSEcCtD
Hydroflumethiazide—Rash—Risedronate—osteoporosis	0.000215	0.00263	CcSEcCtD
Hydroflumethiazide—Dermatitis—Risedronate—osteoporosis	0.000214	0.00263	CcSEcCtD
Hydroflumethiazide—Dizziness—Pamidronate—osteoporosis	0.000214	0.00263	CcSEcCtD
Hydroflumethiazide—Headache—Risedronate—osteoporosis	0.000213	0.00262	CcSEcCtD
Hydroflumethiazide—Asthenia—Zoledronate—osteoporosis	0.000212	0.0026	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00021	0.00257	CcSEcCtD
Hydroflumethiazide—Nausea—Ethinyl Estradiol—osteoporosis	0.000207	0.00254	CcSEcCtD
Hydroflumethiazide—Vomiting—Pamidronate—osteoporosis	0.000206	0.00252	CcSEcCtD
Hydroflumethiazide—Asthenia—Conjugated Estrogens—osteoporosis	0.000204	0.00251	CcSEcCtD
Hydroflumethiazide—Rash—Pamidronate—osteoporosis	0.000204	0.0025	CcSEcCtD
Hydroflumethiazide—Dermatitis—Pamidronate—osteoporosis	0.000204	0.0025	CcSEcCtD
Hydroflumethiazide—Headache—Pamidronate—osteoporosis	0.000203	0.00249	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Zoledronate—osteoporosis	0.000202	0.00248	CcSEcCtD
Hydroflumethiazide—Nausea—Risedronate—osteoporosis	0.000202	0.00248	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—MGLL—osteoporosis	0.000199	0.00336	CbGpPWpGaD
Hydroflumethiazide—Decreased appetite—Estradiol—osteoporosis	0.000198	0.00243	CcSEcCtD
Hydroflumethiazide—Dizziness—Zoledronate—osteoporosis	0.000195	0.0024	CcSEcCtD
Hydroflumethiazide—Constipation—Estradiol—osteoporosis	0.000195	0.00239	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000195	0.00239	CcSEcCtD
Hydroflumethiazide—Nausea—Pamidronate—osteoporosis	0.000192	0.00236	CcSEcCtD
Hydroflumethiazide—Dizziness—Conjugated Estrogens—osteoporosis	0.000188	0.00231	CcSEcCtD
Hydroflumethiazide—Vomiting—Zoledronate—osteoporosis	0.000188	0.00231	CcSEcCtD
Hydroflumethiazide—Rash—Zoledronate—osteoporosis	0.000186	0.00229	CcSEcCtD
Hydroflumethiazide—Dermatitis—Zoledronate—osteoporosis	0.000186	0.00228	CcSEcCtD
Hydroflumethiazide—Headache—Zoledronate—osteoporosis	0.000185	0.00227	CcSEcCtD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000183	0.00309	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLEK—osteoporosis	0.000182	0.00307	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—ANXA2—osteoporosis	0.000182	0.00307	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Conjugated Estrogens—osteoporosis	0.000181	0.00222	CcSEcCtD
Hydroflumethiazide—Urticaria—Estradiol—osteoporosis	0.000181	0.00222	CcSEcCtD
Hydroflumethiazide—Rash—Conjugated Estrogens—osteoporosis	0.000179	0.0022	CcSEcCtD
Hydroflumethiazide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000179	0.0022	CcSEcCtD
Hydroflumethiazide—Headache—Conjugated Estrogens—osteoporosis	0.000178	0.00219	CcSEcCtD
Hydroflumethiazide—Nausea—Zoledronate—osteoporosis	0.000176	0.00215	CcSEcCtD
Hydroflumethiazide—Nausea—Conjugated Estrogens—osteoporosis	0.000169	0.00207	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Estradiol—osteoporosis	0.000168	0.00206	CcSEcCtD
Hydroflumethiazide—CA9—Cellular responses to stress—P4HB—osteoporosis	0.000168	0.00282	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000166	0.0028	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000166	0.0028	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Estradiol—osteoporosis	0.000163	0.00201	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—TLN1—osteoporosis	0.000157	0.00265	CbGpPWpGaD
Hydroflumethiazide—Diarrhoea—Estradiol—osteoporosis	0.000156	0.00191	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—VCL—osteoporosis	0.000155	0.00261	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PKM—osteoporosis	0.000152	0.00257	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—FDPS—osteoporosis	0.000152	0.00257	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Estradiol—osteoporosis	0.000151	0.00185	CcSEcCtD
Hydroflumethiazide—Vomiting—Estradiol—osteoporosis	0.000145	0.00178	CcSEcCtD
Hydroflumethiazide—CA14—Metabolism—PGLS—osteoporosis	0.000144	0.00243	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GPD2—osteoporosis	0.000144	0.00243	CbGpPWpGaD
Hydroflumethiazide—Rash—Estradiol—osteoporosis	0.000144	0.00176	CcSEcCtD
Hydroflumethiazide—Dermatitis—Estradiol—osteoporosis	0.000143	0.00176	CcSEcCtD
Hydroflumethiazide—Headache—Estradiol—osteoporosis	0.000143	0.00175	CcSEcCtD
Hydroflumethiazide—CA7—Metabolism—PKM—osteoporosis	0.000139	0.00233	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—FDPS—osteoporosis	0.000139	0.00233	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PKM—osteoporosis	0.000139	0.00233	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—FDPS—osteoporosis	0.000139	0.00233	CbGpPWpGaD
Hydroflumethiazide—Nausea—Estradiol—osteoporosis	0.000135	0.00166	CcSEcCtD
Hydroflumethiazide—CA14—Metabolism—PNP—osteoporosis	0.000132	0.00222	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ATIC—osteoporosis	0.000132	0.00222	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PGLS—osteoporosis	0.000131	0.00221	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PGLS—osteoporosis	0.000131	0.00221	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPD2—osteoporosis	0.000131	0.00221	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPD2—osteoporosis	0.000131	0.00221	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—RAP1A—osteoporosis	0.00013	0.00218	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—FDPS—osteoporosis	0.000128	0.00216	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PKM—osteoporosis	0.000128	0.00216	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—LEP—osteoporosis	0.000123	0.00206	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPD2—osteoporosis	0.000122	0.00205	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PGLS—osteoporosis	0.000122	0.00205	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ATIC—osteoporosis	0.00012	0.00202	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PNP—osteoporosis	0.00012	0.00202	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ATIC—osteoporosis	0.00012	0.00202	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PNP—osteoporosis	0.00012	0.00202	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—FGA—osteoporosis	0.000117	0.00198	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—OXCT1—osteoporosis	0.000112	0.00189	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CA2—osteoporosis	0.000112	0.00189	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ATIC—osteoporosis	0.000111	0.00187	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PNP—osteoporosis	0.000111	0.00187	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—ADCY5—osteoporosis	0.00011	0.00185	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MGLL—osteoporosis	0.000109	0.00184	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—FGB—osteoporosis	0.000107	0.0018	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PKM—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—FDPS—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—MYC—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—OXCT1—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—OXCT1—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CA2—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CA2—osteoporosis	0.000102	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MGLL—osteoporosis	9.95e-05	0.00168	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MGLL—osteoporosis	9.95e-05	0.00168	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PKM—osteoporosis	9.81e-05	0.00165	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—FDPS—osteoporosis	9.81e-05	0.00165	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPD2—osteoporosis	9.7e-05	0.00163	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PGLS—osteoporosis	9.7e-05	0.00163	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CA2—osteoporosis	9.46e-05	0.00159	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—OXCT1—osteoporosis	9.46e-05	0.00159	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PKM—osteoporosis	9.41e-05	0.00158	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—FDPS—osteoporosis	9.41e-05	0.00158	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PGLS—osteoporosis	9.3e-05	0.00157	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPD2—osteoporosis	9.3e-05	0.00157	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—IDH2—osteoporosis	9.3e-05	0.00157	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MGLL—osteoporosis	9.22e-05	0.00155	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPD2—osteoporosis	8.92e-05	0.0015	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PGLS—osteoporosis	8.92e-05	0.0015	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PNP—osteoporosis	8.88e-05	0.00149	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ATIC—osteoporosis	8.88e-05	0.00149	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD2—osteoporosis	8.84e-05	0.00149	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP27A1—osteoporosis	8.75e-05	0.00147	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PNP—osteoporosis	8.51e-05	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ATIC—osteoporosis	8.51e-05	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ACP5—osteoporosis	8.51e-05	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—IDH2—osteoporosis	8.46e-05	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—IDH2—osteoporosis	8.46e-05	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GPX1—osteoporosis	8.43e-05	0.00142	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—FDPS—osteoporosis	8.27e-05	0.00139	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PKM—osteoporosis	8.27e-05	0.00139	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ATIC—osteoporosis	8.16e-05	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PNP—osteoporosis	8.16e-05	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP27A1—osteoporosis	7.96e-05	0.00134	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP27A1—osteoporosis	7.96e-05	0.00134	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TPI1—osteoporosis	7.91e-05	0.00133	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PGLS—osteoporosis	7.84e-05	0.00132	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPD2—osteoporosis	7.84e-05	0.00132	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—IDH2—osteoporosis	7.84e-05	0.00132	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ACP5—osteoporosis	7.74e-05	0.0013	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ACP5—osteoporosis	7.74e-05	0.0013	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—OXCT1—osteoporosis	7.55e-05	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CA2—osteoporosis	7.55e-05	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—P4HB—osteoporosis	7.44e-05	0.00125	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP27A1—osteoporosis	7.37e-05	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MGLL—osteoporosis	7.35e-05	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GAPDH—osteoporosis	7.3e-05	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—OXCT1—osteoporosis	7.24e-05	0.00122	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TPI1—osteoporosis	7.2e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TPI1—osteoporosis	7.2e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PNP—osteoporosis	7.17e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ATIC—osteoporosis	7.17e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ACP5—osteoporosis	7.17e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—RAP1A—osteoporosis	7.11e-05	0.0012	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MGLL—osteoporosis	7.05e-05	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—OXCT1—osteoporosis	6.94e-05	0.00117	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CA2—osteoporosis	6.94e-05	0.00117	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.88e-05	0.00116	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—P4HB—osteoporosis	6.77e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—P4HB—osteoporosis	6.77e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MGLL—osteoporosis	6.76e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TPI1—osteoporosis	6.67e-05	0.00112	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GAPDH—osteoporosis	6.64e-05	0.00112	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GAPDH—osteoporosis	6.64e-05	0.00112	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—RAP1A—osteoporosis	6.47e-05	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—RAP1A—osteoporosis	6.47e-05	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—P4HB—osteoporosis	6.27e-05	0.00106	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—IDH2—osteoporosis	6.25e-05	0.00105	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.25e-05	0.00105	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.25e-05	0.00105	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GAPDH—osteoporosis	6.15e-05	0.00104	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—OXCT1—osteoporosis	6.1e-05	0.00103	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CA2—osteoporosis	6.1e-05	0.00103	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—IDH2—osteoporosis	6e-05	0.00101	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—RAP1A—osteoporosis	5.99e-05	0.00101	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MGLL—osteoporosis	5.94e-05	0.001	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP27A1—osteoporosis	5.88e-05	0.00099	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—IDH2—osteoporosis	5.75e-05	0.000968	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ENO1—osteoporosis	5.75e-05	0.000968	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ACP5—osteoporosis	5.72e-05	0.000963	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PSMA5—osteoporosis	5.66e-05	0.000954	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PSMA2—osteoporosis	5.66e-05	0.000954	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP27A1—osteoporosis	5.64e-05	0.000949	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ACP5—osteoporosis	5.48e-05	0.000924	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP27A1—osteoporosis	5.4e-05	0.00091	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TPI1—osteoporosis	5.32e-05	0.000896	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ACP5—osteoporosis	5.26e-05	0.000885	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ENO1—osteoporosis	5.23e-05	0.000881	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ENO1—osteoporosis	5.23e-05	0.000881	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PSMA5—osteoporosis	5.15e-05	0.000868	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PSMA2—osteoporosis	5.15e-05	0.000868	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PSMA5—osteoporosis	5.15e-05	0.000868	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PSMA2—osteoporosis	5.15e-05	0.000868	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TPI1—osteoporosis	5.1e-05	0.000859	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—IDH2—osteoporosis	5.05e-05	0.000851	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—P4HB—osteoporosis	5e-05	0.000842	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GAPDH—osteoporosis	4.91e-05	0.000826	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TPI1—osteoporosis	4.89e-05	0.000823	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ENO1—osteoporosis	4.84e-05	0.000816	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IGF1—osteoporosis	4.84e-05	0.000815	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—P4HB—osteoporosis	4.79e-05	0.000807	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—RAP1A—osteoporosis	4.78e-05	0.000805	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PSMA5—osteoporosis	4.77e-05	0.000804	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PSMA2—osteoporosis	4.77e-05	0.000804	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP27A1—osteoporosis	4.75e-05	0.0008	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GAPDH—osteoporosis	4.7e-05	0.000792	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ACP5—osteoporosis	4.62e-05	0.000778	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—P4HB—osteoporosis	4.6e-05	0.000774	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP19A1—osteoporosis	4.6e-05	0.000774	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—RAP1A—osteoporosis	4.58e-05	0.000772	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—osteoporosis	4.58e-05	0.000771	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GAPDH—osteoporosis	4.51e-05	0.00076	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—RAP1A—osteoporosis	4.39e-05	0.00074	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TPI1—osteoporosis	4.3e-05	0.000724	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP19A1—osteoporosis	4.18e-05	0.000704	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP19A1—osteoporosis	4.18e-05	0.000704	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—P4HB—osteoporosis	4.04e-05	0.00068	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GAPDH—osteoporosis	3.97e-05	0.000668	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP19A1—osteoporosis	3.87e-05	0.000652	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ENO1—osteoporosis	3.86e-05	0.000651	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—RAP1A—osteoporosis	3.86e-05	0.00065	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PSMA5—osteoporosis	3.81e-05	0.000641	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PSMA2—osteoporosis	3.81e-05	0.000641	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ADCY5—osteoporosis	3.75e-05	0.000632	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GPX1—osteoporosis	3.74e-05	0.00063	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO1—osteoporosis	3.7e-05	0.000624	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PSMA2—osteoporosis	3.65e-05	0.000615	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PSMA5—osteoporosis	3.65e-05	0.000615	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO1—osteoporosis	3.55e-05	0.000598	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PSMA2—osteoporosis	3.5e-05	0.000589	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PSMA5—osteoporosis	3.5e-05	0.000589	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—osteoporosis	3.45e-05	0.000582	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ADCY5—osteoporosis	3.42e-05	0.000575	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ADCY5—osteoporosis	3.42e-05	0.000575	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPX1—osteoporosis	3.4e-05	0.000573	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPX1—osteoporosis	3.4e-05	0.000573	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ADCY5—osteoporosis	3.16e-05	0.000533	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPX1—osteoporosis	3.15e-05	0.000531	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—osteoporosis	3.14e-05	0.000529	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—osteoporosis	3.14e-05	0.000529	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO1—osteoporosis	3.12e-05	0.000526	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP19A1—osteoporosis	3.09e-05	0.00052	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PSMA2—osteoporosis	3.08e-05	0.000518	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PSMA5—osteoporosis	3.08e-05	0.000518	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP19A1—osteoporosis	2.96e-05	0.000499	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—osteoporosis	2.91e-05	0.00049	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—osteoporosis	2.9e-05	0.000489	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP19A1—osteoporosis	2.84e-05	0.000478	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—POMC—osteoporosis	2.76e-05	0.000465	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—osteoporosis	2.71e-05	0.000456	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ADCY5—osteoporosis	2.52e-05	0.000425	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPX1—osteoporosis	2.51e-05	0.000424	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—POMC—osteoporosis	2.51e-05	0.000423	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—POMC—osteoporosis	2.51e-05	0.000423	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP19A1—osteoporosis	2.5e-05	0.00042	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ADCY5—osteoporosis	2.42e-05	0.000407	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPX1—osteoporosis	2.41e-05	0.000406	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—POMC—osteoporosis	2.33e-05	0.000392	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—osteoporosis	2.32e-05	0.000391	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ADCY5—osteoporosis	2.32e-05	0.000391	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPX1—osteoporosis	2.31e-05	0.000389	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—osteoporosis	2.23e-05	0.000375	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—osteoporosis	2.13e-05	0.000359	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ADCY5—osteoporosis	2.04e-05	0.000343	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPX1—osteoporosis	2.03e-05	0.000342	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—osteoporosis	1.88e-05	0.000316	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—POMC—osteoporosis	1.86e-05	0.000313	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—POMC—osteoporosis	1.78e-05	0.0003	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—POMC—osteoporosis	1.71e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—POMC—osteoporosis	1.5e-05	0.000253	CbGpPWpGaD
